Poster
SI-B001 plus chemotherapy in patients with locally advanced or metastatic EGFR/ALK wild-type non-small cell lung cancer: A phase II, multicenter, open-label study
Author
Yuanyuan Zhao
Condition
EGFR/ALK wild-type non-small cell lung cancer
Source url
s3://convoke-optic-posters/2024-05-10/ASCO-SI-B001-201.pdf
4 organizations
1 product
Product
SI-B001Organization
SystImmune, Inc., Redmond, WA